Los Angeles Capital Management LLC Buys 107,868 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Los Angeles Capital Management LLC boosted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 404.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,544 shares of the company’s stock after acquiring an additional 107,868 shares during the quarter. Los Angeles Capital Management LLC owned 0.06% of Bath & Body Works worth $4,295,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in BBWI. Anomaly Capital Management LP bought a new position in Bath & Body Works in the 2nd quarter valued at $113,995,000. Lone Pine Capital LLC increased its stake in shares of Bath & Body Works by 15.8% in the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after buying an additional 1,547,399 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Bath & Body Works by 4.2% in the first quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock valued at $1,370,458,000 after buying an additional 1,102,124 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in Bath & Body Works by 723.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,167,554 shares of the company’s stock worth $37,268,000 after buying an additional 1,025,757 shares in the last quarter. Finally, Interval Partners LP grew its holdings in Bath & Body Works by 230.0% during the 2nd quarter. Interval Partners LP now owns 1,280,593 shares of the company’s stock worth $50,007,000 after acquiring an additional 892,488 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Insider Buying and Selling at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of Bath & Body Works stock in a transaction dated Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on BBWI. Bank of America reduced their target price on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a research report on Thursday, August 29th. Raymond James lowered their target price on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Wells Fargo & Company cut their price target on Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 6th. Morgan Stanley lowered their price objective on Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating for the company in a research report on Thursday, September 5th. Finally, Evercore ISI cut their target price on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a research report on Wednesday, August 28th. One analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $42.44.

Bath & Body Works Stock Up 0.2 %

NYSE:BBWI opened at $31.58 on Wednesday. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The firm has a market capitalization of $6.92 billion, a price-to-earnings ratio of 7.65, a price-to-earnings-growth ratio of 0.95 and a beta of 1.79. The stock’s 50 day moving average price is $30.04 and its two-hundred day moving average price is $36.67.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, analysts anticipate that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.